News / Events :: BioXcel Therapeutics, Inc. (BTAI)

Recent News View All News

BioXcel Therapeutics Announces BXCL501 Met the Primary and All Secondary Endpoints in the TRANQUILITY Phase 1b/2 Study for the Acute Treatment of Agitation in Dementia, including Alzheimer’s Disease

January 5, 2021

BioXcel Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

December 17, 2020

Recent Events View IR Calendar

39th Annual J.P. Morgan Healthcare Conference

Jan 14, 2021 • 8:20am EST

TRANQUILITY Phase 1b/2 Trial Topline Results Conference Call

Jan 5, 2021 • 8:30am EST

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings